Supplement Industry Waits For “Friendlier” MedWatch Form
This article was originally published in The Tan Sheet
Executive Summary
FDA changes MedWatch form 3500A to accommodate medical device firms’ needs, but will not make changes to facilitate reporting AERs for drug, supplement or food products. The agency and supplement industry stakeholders agree 3500A is not ideal for supplement AERs.
You may also be interested in...
Burton Bill Would Move Up New Dietary Ingredient Grandfather Date To 2007
Rep. Burton offers legislation to move up from 1994 to 2007 the date delineating old from new dietary ingredients. Despite the appeal, supplement trade groups are leery of opening up DSHEA to amendment.
FDA Says Supplement Adverse Event Under-Reporting Should Feed Growth
FDA published a how-to guide to push dietary supplement firms toward tighter compliance with the requirement to submit serious adverse event reports to the agency.
Along With All NDAs Submitted To US FDA In FY2023, Costs For OTC Switch Proposals Increase
Agency publishes Prescription Drug User Fee Act rates for FY2023, the first of five covered in reauthorization of program Congress approved on 30 September as legislation added to a continuing resolution to fund federal agencies through 16 December.